Özcelik Dennis, Seto Andrew, Rakic Bojana, Farzam Ali, Supek Frantisek, Pezacki John Paul
Department of Chemistry and Biomolecular Sciences, University of Ottawa, 10 Marie Curie Street, Ottawa, Ontario K1N 6N5, Canada.
Department of Genetics & Neglected Diseases, Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, United States.
ACS Omega. 2018 Dec 31;3(12):17227-17235. doi: 10.1021/acsomega.8b02676. Epub 2018 Dec 13.
Protein disulfide isomerases (PDIs) catalyze disulfide bond formation between protein cysteine residues during protein folding in the endoplasmic reticulum (ER) lumen and are essential for maintaining ER homoeostasis. The life cycle of the hepatitis C virus (HCV) is closely associated with the ER. Synthesis and maturation of HCV proteins occur in the ER membrane and are mediated by multiple host cell factors that include also PDI. Here, we present a study investigating the effect of PDI inhibition on Huh7 human hepatoma cells harboring an HCV subgenomic replicon using the abscisic acid-derived PDI inhibitor origamicin. Transcriptional profiling shows that origamicin changed the expression levels of genes involved in the oxidative and ER stress responses and the unfolded protein response, as indicated by the upregulation of antioxidant enzymes and chaperone proteins, the downregulation of cell-cycle proteins, and induction of apoptosis-associated genes. Our data suggest that origamicin negatively impacts HCV replication by causing an imbalance in cellular homoeostasis and induction of stress responses. These insights suggest that inhibition of PDIs by low-molecular-weight inhibitors could be a promising approach to the discovery of novel antiviral compounds.
蛋白质二硫键异构酶(PDIs)在内质网(ER)腔中蛋白质折叠过程中催化蛋白质半胱氨酸残基之间的二硫键形成,对于维持内质网稳态至关重要。丙型肝炎病毒(HCV)的生命周期与内质网密切相关。HCV蛋白的合成和成熟在内质网膜中发生,并由包括PDI在内的多种宿主细胞因子介导。在此,我们展示了一项研究,该研究使用脱落酸衍生的PDI抑制剂奥瑞米星,研究PDI抑制对携带HCV亚基因组复制子的Huh7人肝癌细胞的影响。转录谱分析表明,奥瑞米星改变了参与氧化应激反应、内质网应激反应和未折叠蛋白反应的基因表达水平,这表现为抗氧化酶和伴侣蛋白的上调、细胞周期蛋白的下调以及凋亡相关基因的诱导。我们的数据表明,奥瑞米星通过导致细胞内稳态失衡和诱导应激反应,对HCV复制产生负面影响。这些见解表明,用低分子量抑制剂抑制PDIs可能是发现新型抗病毒化合物的一种有前景的方法。